ClinVar Miner

Submissions for variant NM_000350.3(ABCA4):c.629del (p.Leu210fs)

dbSNP: rs2101135952
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001387654 SCV001588326 pathogenic not provided 2024-02-02 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Leu210Argfs*31) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ABCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1074381). For these reasons, this variant has been classified as Pathogenic.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV002551560 SCV003761283 likely pathogenic ABCA4-related retinopathy 2023-01-25 criteria provided, single submitter curation The heterozygous p.Leu210ArgfsTer31 variant in ABCA4 was identified by our study, in the compound heterozygous state with a pathogenic variant (ClinVar Variation ID: 7882), in one individual with rod-cone dystrophy. This individual also carried a pathogenic variant (ClinVar Variation ID: 7882); however, the phase of these variants is unknown at this time. The p.Leu210ArgfsTer31 variant in ABCA4 has not been previously reported in individuals with autosomal recessive ABCA4-related retinopathy. This variant was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 1074381) and has been interpreted as pathogenic by Invitae. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 210 and leads to a premature termination codon 31 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ABCA4 gene is an established disease mechanism in autosomal recessive ABCA4-related retinopathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive ABCA4-related retinopathy. ACMG/AMP Criteria applied: PVS1, PM2_Supporting (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.